Detalhe da pesquisa
1.
MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples.
Brief Bioinform
; 24(2)2023 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36653909
2.
CHD8 suppression impacts on histone H3 lysine 36 trimethylation and alters RNA alternative splicing.
Nucleic Acids Res
; 50(22): 12809-12828, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36537238
3.
Genomic correlates of clinical outcome in advanced prostate cancer.
Proc Natl Acad Sci U S A
; 116(23): 11428-11436, 2019 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31061129
4.
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial.
Breast Cancer Res
; 23(1): 38, 2021 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33761970
5.
Tumor Necrosis Factor α Influences Phenotypic Plasticity and Promotes Epigenetic Changes in Human Basal Forebrain Cholinergic Neuroblasts.
Int J Mol Sci
; 21(17)2020 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32854421
6.
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial.
Breast Cancer Res
; 21(1): 71, 2019 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31142370
7.
Tumor purity quantification by clonal DNA methylation signatures.
Bioinformatics
; 34(10): 1642-1649, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29325057
8.
ddSeeker: a tool for processing Bio-Rad ddSEQ single cell RNA-seq data.
BMC Genomics
; 19(1): 960, 2018 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30583719
9.
A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients.
Breast Cancer Res Treat
; 170(2): 329-341, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29564743
10.
A novel founder MYO15A frameshift duplication is the major cause of genetic hearing loss in Oman.
J Hum Genet
; 62(2): 259-264, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27734841
11.
CEBPA-double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features.
Haematologica
; 102(3): 529-540, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28250006
12.
H3M2: detection of runs of homozygosity from whole-exome sequencing data.
Bioinformatics
; 30(20): 2852-9, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24966365
13.
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.
JCO Precis Oncol
; 8: e2300285, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38427931
14.
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation.
Cancer Discov
; 14(3): 424-445, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38197680
15.
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer.
Sci Transl Med
; 16(736): eadf9874, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416843
16.
Read count approach for DNA copy number variants detection.
Bioinformatics
; 28(4): 470-8, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22199393
17.
Discovering chimeric transcripts in paired-end RNA-seq data by using EricScript.
Bioinformatics
; 28(24): 3232-9, 2012 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23093608
18.
Detecting common copy number variants in high-throughput sequencing data by using JointSLM algorithm.
Nucleic Acids Res
; 39(10): e65, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21321017
19.
Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients.
Transl Oncol
; 27: 101585, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36403505
20.
Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trial.
Eur J Cancer
; 186: 1-11, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37003098